RecruitingPhase 3NCT03770702
Statins and ARBs on Rheumatoid Activity
Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients
Sponsor
Sherief Abd-Elsalam
Enrollment
45 participants
Start Date
Oct 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria1
- Rheumatoid arthritis.
Exclusion Criteria2
- Pregnant or lactating
- Hepatic or renal impairment.
Interventions
DRUGStatins
Atorvastatin
DRUGAngiotensin receptor blockers
Candesartan
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03770702
Related Trials
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
NCT068415621 location
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
NCT0710093829 locations
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT0691680633 locations
Biobank for Inflammatory Chronic Diseases and Osteoporosis
NCT050392161 location